To give you the best possible experience, this site uses cookies. Using your site means your agree to our use of cookies. We have published a new cookies policy, which you should need to find out more about the cookies we use. View Cookies Policy.

EPIGSOIN develops innovative natural solutions based on the bioactive compounds of Nigella sativa, leveraging advances in molecular biology and epigenetics. We design science-driven formulations aimed at supporting physiological balance and resilience, at the intersection of specialized nutrition and dermocosmetics.

Our approach is supported by active research and development, with several patent applications in progress, reflecting the innovative nature of our processes and formulations. Through our products, we translate scientific research into effective, natural solutions tailored to modern health needs.

Our mission:

To transform science into high-performance natural solutions that sustainably improve health, well-being, and physiological balance.

Our Team:

EPIGSOIN was founded by Professor Dr Mahmoud Alhosin, a pharmacist and PhD in cellular and molecular biology, with the ambition to develop innovative natural solutions with high biological potential.

At the intersection of molecular biology and epigenetics, EPIGSOIN adopts a science-driven approach aimed at exploring the role of natural bioactives in supporting physiological balance and the body’s resilience.

Scientific expertise:

Professor Dr Mahmoud Alhosin obtained his PhD from the Faculty of Pharmacy at the University of Strasbourg (France). A recognized expert in cancer epigenetics, his work has contributed to the understanding of key regulatory mechanisms involving proteins such as UHRF1, DNMT1, and HDAC1.

His research has particularly focused on the interaction between natural compounds and epigenetic regulation, opening new perspectives in the identification of bioactive compounds of interest for health.

International recognition:

His work has been published in numerous peer-reviewed scientific journals, including Oncogene, European Journal of Cancer, Biochemical Pharmacology, Cell Signalling, and the International Journal of Biochemistry & Cell Biology.

From research to innovation:

Building on this expertise, EPIGSOIN develops science-based natural solutions, particularly by leveraging the bioactive potential of Nigella sativa.

Our goal is to translate scientific research into high-quality formulations that meet the highest standards of naturalness, safety, and performance.